Purdue Pharma Canada says in a letter to the federal health minister that it wants to help address the opioid crisis but the company denies any wrongdoing in the way it promoted OxyContin in Canada.
Tag: OxyContin
Canada should launch a criminal investigation into the marketing of OxyContin
For now, Canada has left it to the victims of the opioid crisis to seek their own justice, which they have attempted to do through a class-action lawsuit.
OxyContin maker to appeal judge’s decision to spurn $20M Canadian settlement
A Saskatchewan judge’s concerns about the real costs of addiction recovery halted a settlement agreement between Purdue Pharma and hundreds of people who were prescribed OxyContin.
Saskatchewan judge rejects $20M class action settlement with Oxycontin maker
Justice Brian Barrington-Foote of Regina’s Court of Queen’s Bench released a decision stating that he was not satisfied the settlement was “fair, reasonable and in the best interests of the class as a whole.”
Purdue will stop forcefully pushing OxyContin, focus on constipation instead
Enlarge (credit: Getty | Bloomberg) Purdue Pharma LP, the maker of opioid painkiller OxyContin, said that it will stop aggressively promoting opioid painkillers directly to doctors—a practice many blamed for helping to create the epidemic of opioid addiction and overdose that has recently been killing an average of 115 Americans each day. According to Bloomberg, […]
OxyContin maker Purdue says it will stop marketing opioids to U.S. doctors
The maker of the powerful painkiller OxyContin said it will stop marketing opioid drugs to doctors, bowing to a key demand of lawsuits that blame the company for helping trigger the current drug abuse epidemic.
New Jersey becomes latest state to sue Purdue Pharma over OxyContin
State attorney general points ‘finger of blame’ at Purdue for the opioid epidemic he says has killed thousands in New Jersey. CBC | Health News
Nova Scotia judge signs off on OxyContin class-action settlement
A Nova Scotia judge has approved a settlement in the class-action lawsuit related to OxyContin, even as two people affected by addiction to the painkiller told the court Tuesday they were unhappy with the deal struck with the drug manufacturer. CBC | Health News
Ottawa pushed to prosecute Purdue Pharma over ‘deceptive’ marketing of OxyContin
A decade ago, OxyContin’s drugmaker Purdue Pharma settled civil and criminal suits in the U.S. for more than $ 600 million US. After a recently proposed $ 20 million settlement in Canada, doctors and lawyers here are calling for criminal prosecution. CBC | Health News
OxyContin maker agrees to $20M settlement in Canadian class-action case
OxyContin maker Purdue Pharma has agreed to pay $ 20 million to settle a class-action lawsuit involving allegations about how the pain pills were marketed. CBC | Health News
